Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques
Infection with the novel coronavirus, SARS-CoV-2, results in pneumonia and other respiratory symptoms as well as pathologies at diverse anatomical sites. An outstanding question is whether these diverse pathologies are due to replication of the virus in these anatomical compartments and how and when...
Saved in:
Published in | Frontiers in immunology Vol. 12; p. 810047 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
24.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Infection with the novel coronavirus, SARS-CoV-2, results in pneumonia and other respiratory symptoms as well as pathologies at diverse anatomical sites. An outstanding question is whether these diverse pathologies are due to replication of the virus in these anatomical compartments and how and when the virus reaches those sites. To answer these outstanding questions and study the spatiotemporal dynamics of SARS-CoV-2 infection a method for tracking viral spread
is needed. We developed a novel, fluorescently labeled, antibody-based
probe system using the anti-spike monoclonal antibody CR3022 and demonstrated that it could successfully identify sites of SARS-CoV-2 infection in a rhesus macaque model of COVID-19. Our results showed that the fluorescent signal from our antibody-based probe could differentiate whole lungs of macaques infected for 9 days from those infected for 2 or 3 days. Additionally, the probe signal corroborated the frequency and density of infected cells in individual tissue blocks from infected macaques. These results provide proof of concept for the use of
antibody-based probes to study SARS-CoV-2 infection dynamics in rhesus macaques. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology Edited by: Krishanu Ray, University of Maryland, United States Reviewed by: James J. Kobie, University of Alabama at Birmingham, United States; Li Liu, The University of Hong Kong, Hong Kong SAR, China |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2021.810047 |